Keywords: ivax, revenues, hit, record, high, miami, usa-based
IVAX' 2003 revenues hit record high
Article | 01 March 2004
Miami, USA-based IVAX Corp has reported record fourth-quarter and full-year 2003 net revenues, up 23% to $399 million and 19% to $1.42 billion, respectively.
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
